CAPRISA scientists present research on bNAbs vaccines at AIDS 2018
In addition to several posters, several of CAPRISA’s scientists contributed to sessions at the 22nd International AIDS Society Conference, themed “Breaking Barriers, Building Bridges”, held in Amsterdam, Netherlands from 23-27 July. CAPRISA’s research on broadly neutralising antibodies and vaccine research featured prominently in presentations made by CAPRISA Research associates, Professors Penny Moore and Lynn Morris.
Moore delivered a talk entitled “Broadly neutralizing antibodies for HIV prevention and treatment” in a well-attended symposium entitled “Biomedical research innovations in the prevention, remission and cure of HIV/AIDS”, which included Dr Tony Fauci (Director of the National Institute of Allergy and Infectious Diseases), Prof Glenda Gray (President of the South African Medical Research Council) and Dr Peter Piot (Director London School of Hygiene and Tropical Medicine).
In a session entitled “Breaking down barriers: HIV intervention in sub-Saharan Africa”, chaired by Professor Quarraisha Abdool Karim (Associate Scientific Director, CAPRISA) and Professor Catherine Hankins (Deputy Director Science, Amsterdam Institute for Global Health and Development), Morris gave a talk entitled “Building research excellence in HIV vaccine science” and summarized the importance of vaccine development from an African prospective. Morris also presented research carried out by NICD PhD student Simone Richardson, in a talk entitled “bNAbs for clinical use: antiviral activity and effector functions other than neutralization”.